Avascular Necrosis, CTCAE
|
phenotype |
|
Finding
|
41
|
|
0.100 |
None |
|
0 |
|
|
|
Memory Impairment, CTCAE 5.0
|
phenotype |
|
Finding
|
108
|
|
0.100 |
None |
|
0 |
|
|
|
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.100 |
None |
1.000 |
31 |
3
|
1992 |
2019 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1408
|
42
|
0.100 |
None |
0.960 |
25 |
1
|
1992 |
2019 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.100 |
None |
1.000 |
14 |
|
1992 |
2019 |
Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
556
|
13
|
0.100 |
None |
1.000 |
13 |
|
1992 |
2012 |
Adult Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
475
|
7
|
0.100 |
None |
1.000 |
12 |
|
1992 |
2012 |
Childhood Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
477
|
7
|
0.100 |
None |
1.000 |
12 |
|
1992 |
2012 |
Acquired Immunodeficiency Syndrome
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
243
|
42
|
0.080 |
None |
0.875 |
8 |
1
|
1992 |
2010 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.967 |
240 |
2
|
1993 |
2020 |
Leishmaniasis, Visceral
|
disease |
Infections
|
Disease or Syndrome
|
197
|
22
|
0.400 |
None |
1.000 |
27 |
3
|
1993 |
2019 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.400 |
None |
0.962 |
26 |
|
1993 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.100 |
None |
1.000 |
19 |
3
|
1993 |
2019 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.100 |
None |
1.000 |
19 |
3
|
1993 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.100 |
None |
1.000 |
11 |
3
|
1993 |
2019 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.100 |
None |
1.000 |
10 |
3
|
1993 |
2016 |
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
384
|
72
|
0.100 |
None |
1.000 |
10 |
1
|
1993 |
2017 |
Mycobacterium Infections
|
group |
Infections
|
Disease or Syndrome
|
183
|
14
|
0.080 |
None |
0.875 |
8 |
1
|
1993 |
2019 |
Post-kala-azar dermal leishmaniasis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
28
|
|
0.050 |
None |
0.800 |
5 |
|
1993 |
2017 |
Mantle cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
466
|
19
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2019 |
Diffuse cutaneous leishmaniasis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
22
|
|
0.030 |
None |
1.000 |
3 |
|
1993 |
2019 |
Severe Combined Immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
284
|
46
|
0.020 |
None |
1.000 |
2 |
|
1993 |
1999 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Toxic Epidermal Necrolysis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders; Stomatognathic Diseases
|
Disease or Syndrome
|
143
|
29
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Leukemia, Mast-Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
75
|
7
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |